Ember in-licenses BMP7 IP from diabetes center

The Joslin Diabetes Center granted obesity and diabetes company Ember Therapeutics Inc. (Boston, Mass.) exclusive, worldwide rights to IP covering bone morphogenetic protein 7 ( BMP7; OP-1). The company said BMP7 has been shown to play a role in the regulation of brown fat development -- brown fat burns calories to generate heat. Research investigating the role of BMP7 in brown fat was led in part by C. Ronald Kahn, one of Ember's co-founders. Financial details were not disclosed. ...